Circulating Follicular Regulatory T Cells in Autoimmune Diseases and Their Waning in Multiple Sclerosis

被引:1
作者
Dhaeze, Tessa [1 ,2 ,3 ,4 ]
Hellings, Niels [3 ,4 ]
机构
[1] Univ Montreal, Hosp Ctr CRCHUM, Res Ctr, 900 Rue St Denis, Montreal, PQ H2X 0A9, Canada
[2] Univ Montreal, Dept Neurosci, Fac Med, 900 Rue St Denis, Montreal, PQ H2X 0A9, Canada
[3] Hasselt Univ, Biomed Res Inst, Agoralaan Bldg C, B-3590 Diepenbeek, Belgium
[4] Transnatl Univ Limburg, Sch Life Sci, Agoralaan Bldg C, B-3590 Diepenbeek, Belgium
关键词
circulating follicular regulatory T cells; autoimmune disease; germinal center; follicular helper T cells; multiple sclerosis; therapy; SYSTEMIC-LUPUS-ERYTHEMATOSUS; MESSENGER-RNA EXPRESSION; CXC CHEMOKINE RECEPTOR-5; GERMINAL CENTER RESPONSE; CENTRAL-NERVOUS-SYSTEM; B-CELLS; CEREBROSPINAL-FLUID; HUMAN BLOOD; HUMORAL AUTOIMMUNITY; INCREASED FREQUENCY;
D O I
10.1615/CritRevImmunol.2017019850
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Follicular regulatory T cells (T(FR)s) are a subset of regulatory T cells that reside in the secondary lymphoid organs and participate in controlling the germinal center (GC) response. The GC response forms the basis of adaptive immunity to foreign protein antigens. In autoimmune diseases, hyperreactivity to self-antigens occurs that may result from an aberrant control of the GC response. T-FR dysfunctionality may be one of the factors contributing to this breakdown of self-tolerance. In this review, we discuss how the investigation of circulating TFRs can help us understand their relative contribution to autoimmune-mediated disease processes. Multiple sclerosis is taken as a classical example of autoimmune disease.
引用
收藏
页码:511 / 522
页数:12
相关论文
共 50 条
  • [31] CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells?
    Agahozo, Marie Colombe
    Peferoen, Laura
    Baker, David
    Amor, Sandra
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 9 : 110 - 117
  • [32] Regulatory T cells and B cells: implication on autoimmune diseases
    Wang, Ping
    Zheng, Song Guo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2013, 6 (12): : 2668 - 2674
  • [33] Harnessing regulatory T cells for the therapy of lupus and other autoimmune diseases
    Sharabi, Amir
    Mozes, Edna
    IMMUNOTHERAPY, 2009, 1 (03) : 385 - 401
  • [34] T-regulatory cells for the treatment of autoimmune diseases
    Fisher, Marina S.
    Sennikov, Sergey V.
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [35] A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis
    Ray, Avijit
    Mann, Monica K.
    Basu, Sreemanti
    Dittel, Bonnie N.
    JOURNAL OF NEUROIMMUNOLOGY, 2011, 230 (1-2) : 1 - 9
  • [36] Regulatory B cells in autoimmune diseases
    Yang, Min
    Rui, Ke
    Wang, Shengjun
    Lu, Liwei
    CELLULAR & MOLECULAR IMMUNOLOGY, 2013, 10 (02) : 122 - 132
  • [37] Imbalance of regulatory T cells in human autoimmune diseases
    Dejaco, C
    Duftner, C
    Grubeck-Loebenstein, B
    Schirmer, M
    IMMUNOLOGY, 2006, 117 (03) : 289 - 300
  • [38] The role of regulatory T cells in multiple sclerosis
    Zozulya, Alla L.
    Wiendl, Heinz
    NATURE CLINICAL PRACTICE NEUROLOGY, 2008, 4 (07): : 384 - 398
  • [39] Role of T-regulatory cells in multiple sclerosis.
    Ignacio Rojas, Juan
    Gonzalez, Sergio J.
    Patrucco, Liliana
    Cristiano, Edgardo
    MEDICINA-BUENOS AIRES, 2010, 70 (01) : 79 - 86
  • [40] Altered ratio of circulating follicular regulatory T cells and follicular helper T cells during primary EBV infection
    Jiang Qian
    Qinhua Yu
    Guoqing Chen
    Mingxia Wang
    Zhao Zhao
    Yueyue Zhang
    Liannv Qiu
    Clinical and Experimental Medicine, 2020, 20 : 373 - 380